Optimal Treatment for Kidney Disease in HIV Infected Adults
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The angiotensin receptor blocker (ARB) valsartan is a drug commonly used to treat high blood
pressure. Valsartan may also help slow down the progression of kidney disease in HIV infected
people. The purpose of this study is to compare valsartan and antiretroviral therapy (ART) to
ART alone in slowing kidney disease progression in people with HIV.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)